NCT04752722 2026-01-26
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
enGene, Inc.
Phase 1/2 Recruiting
enGene, Inc.
Memorial Sloan Kettering Cancer Center
Lamassu Bio Inc
AtlasMedx, Incorporated
Children's Hospital of Philadelphia
European Institute of Oncology